mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0059 |
0.9 |
mRNA |
temsirolimus |
FIMM |
pan-cancer |
AAC |
-0.2 |
0.2 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.5 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.0076 |
0.8 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
0.0048 |
0.9 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.1 |